G7048

Proguanil hydrochloride

≥95% (HPLC)

• Synonim(y): Chlorguanide, N¹-(4-Chlorophenyl)-N⁵-isopropylbiguanide
• Wzór empiryczny (zapis Hilla): C₁₁H₁₆ClN₅·HCl
• Numer CAS: 637-32-1
• Masa cząsteczkowa: 290.19
• NACRES: NA.77
• PubChem Substance ID: 329799959
• UNSPSC Code: 51101906
• EC Number: 211-283-7
• MDL number: MFCD01732193
• Assay: ≥95% (HPLC)
• Form: solid
• Storage condition: desiccated

Właściwości

• Quality Segment: 100
• assay: ≥95% (HPLC)
• form: solid
• storage condition: desiccated
• solubility: acetonitrile: water: ~1 mg/mL (60/40)
• originator: AstraZeneca
• storage temp.: 2-8°C
• SMILES string: Cl.CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
• InChI: 1S/C11H16ClN5.ClH/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9;/h3-7H,1-2H3,(H5,13,14,15,16,17);1H
• InChI key: SARMGXPVOFNNNG-UHFFFAOYSA-N

Opis

Application

Proguanil (chlorguanide) may be used in anti-parasitic protozoan drug development to study its pharmacokinetics, metabolism, safety, efficacy and methods of delivery as an antimalarial drug.

Biochem/physiol Actions

Chlorguanide (proguanil) is combined with atovaquone for malaria prophylaxis. The two compounds act synergistically to inhibit the plasmodial dihydrofolate reductase (DHFR) and interrupt the electron transport chain. Mutations in DHFR account for the development of resistant strains.

Proguanil hydrochloride is antimalarial. Dihydrofolate reductase inhibitor

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable